This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Can Prestige Consumer's Solid Healthcare Unit Aid Recovery?
by Zacks Equity Research
Prestige Consumer (PBH) witnesses strong consumption trends in healthcare. However, declining revenues remain concerns.
PVH Corp Raises View, Reorganizes Calvin Klein Unit, Stock Up
by Zacks Equity Research
PVH Corp (PVH) raises adjusted earnings projection for the fourth quarter and fiscal 2018. Further, it plans to restructure its Calvin Klein business.
Major Indexes Out of Correction Territory: 5 Top Picks
by Nalak Das
Positive developments on trade war front and Fed's monetary stance are likely to boost investor sentiment in the near-term resulting in further consolidation of the indexes.
Crocs (CROX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Crocs (CROX) closed at $31.10, marking a -0.86% move from the previous day.
J.C. Penney Holiday Comps Fall, Store Closures in the Cards
by Zacks Equity Research
J. C. Penney (JCP) plans to shut down three stores post its dismal show in the recent holiday season.
Under Armour Looks Lucrative Despite Tumbling 17% in a Month
by Zacks Equity Research
Although sluggish sales in North America persists, expansion of DTC business and restructuring initiatives are likely to aid Under Armour's (UAA) growth in the near future.
NIKE Outpaces S&P 500 in a Year: Will the Momentum Continue?
by Zacks Equity Research
NIKE (NKE) is performing impressively, backed by the Consumer Direct Offense strategy, and NIKE Digital and NIKE Direct businesses.
GameStop (GME) Stock Rallies More Than 17% on Buyout Hearsays
by Zacks Equity Research
GameStop (GME) is rumored to announce a deal related to its own buyout in February, after several failed attempts to redeem growth.
Zacks.com featured expert Kevin Matras highlights: Crocs, Novanta, Abercrombie & Fitch and Bruker
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Crocs, Novanta, Abercrombie & Fitch and Bruker
Columbia Sportswear Buys Pending Stake in China Joint Venture
by Zacks Equity Research
Columbia Sportswear's (COLM) latest move to acquire remaining stake in the joint venture with Swire is likely to bolster business in China.
Tap 4 Best-Performing Liquid Bets to Boost Portfolio Returns
by Zacks Equity Research
Here are four top-notch liquid stocks that can make a winning portfolio for investors.
Top Ranked Momentum Stocks to Buy for January 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 3rd
Can Columbia Sportswear's Growth Efforts Pare SG&A Cost Woes?
by Zacks Equity Research
Columbia Sportswear (COLM) focuses on boosting efficiency through Project CONNECT. However, high SG&A costs are a worry.
Can Crocs (CROX) Stock Continue to Grow Earnings?
by Zacks Equity Research
Crocs (CROX) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Is Crocs (CROX) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Is (CROX) Outperforming Other Consumer Discretionary Stocks This Year?
Can PVH Corp's Strategies Help Gain Lost Momentum in 2019?
by Zacks Equity Research
PVH Corp (PVH) witnesses softness across its Calvin Klein business in the third quarter. However, the company's brand management and e-commerce initiatives appear promising.
Zacks.com featured highlights include: Abercrombie & Fitch, La-Z-Boy, Crocs, Spirit Airlines and PennyMac Mortgage Investment
by Zacks Equity Research
Zacks.com featured highlights include: Abercrombie & Fitch, La-Z-Boy, Crocs, Spirit Airlines and PennyMac Mortgage Investment
4 Reasons Why Ralph Lauren is a Valued Investment for 2019
by Zacks Equity Research
Ralph Lauren (RL) seems poised for growth in 2019, backed by the expansion of digital and international presence. Further, the Next Great Chapter Plan shows potential.
Can Hanesbrands' (HBI) Strategic Efforts Aid a Turnaround?
by Zacks Equity Research
Hanesbrands (HBI) is battling raw material inflation, softness in innerwear and adverse currency fluctuations. However, the company is taking initiatives to help the stock revive in the long run.
G-III Apparel's Strong Fundamentals Place it Firmly for 2019
by Zacks Equity Research
G-III Apparel (GIII) looks quite disciplined in its approach of tackling prevailing headwinds in the retail landscape.
Snap-on Down More than 22% in 6 Months: Can the Stock Revive?
by Zacks Equity Research
Snap-On's (SNA) soft performance in the Tools Group segment and high input costs remain matters of concern. However, solid business model and acquisitions are likely to drive growth.
Carter's Down 30% in a Year: Can Strategies Aid a Turnaround?
by Zacks Equity Research
Carter's (CRI) witnesses softness across its U.S. Wholesale business. Nevertheless, the company's Retail strategy that focuses on improving store productivity is impressive.
5 Stocks With Impressive Relative Price Strength to Scoop Up
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Zacks.com featured highlights include: Crocs, Abercrombie & Fitch, salesforce.com and Sprint
by Zacks Equity Research
Zacks.com featured highlights include: Crocs, Abercrombie & Fitch, salesforce.com and Sprint
5 Nasdaq Composite Stocks That Braved the Index's Bloodbath
by Nalak Das
Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.